{
    "clinical_study": {
        "@rank": "131143", 
        "brief_summary": {
            "textblock": "In this part of the Registry Program patients with non-valvular atrial fibrillation (AF) at\n      risk for stroke are enrolled to characterize the target population and to collect real world\n      data on important outcome events. For administrative purposes the study is divided into\n      three protocol numbers: 1160.129 for all non-EU (European Union) and non-EEA (European\n      Economic Area) countries, 1160.136 for EU and EEA countries and 1160.171 for India and\n      Switzerland. The total number of patients enrolled in three protocols is estimated to be\n      48,000 patients, and all these patients will be included in the data analysis for study\n      1160.129."
        }, 
        "brief_title": "GLORIA-AF Registry Program (Phase II/III)", 
        "completion_date": {
            "#text": "January 2020", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Stroke", 
            "Atrial Fibrillation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atrial Fibrillation", 
                "Stroke"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n        1) Patients newly diagnosed with non-valvular atrial fibrillation (NVAF) at risk for\n        stroke.\n\n        Exclusion criteria:\n\n          1. Presence of any mechanical heart valve, or valve disease that is expected to require\n             valve replacement intervention;\n\n          2. Patients who have received more than 60 days of vitamin K antagonist (VKA) treatment\n             in their lifetime;\n\n          3. AF with a generally reversible cause;\n\n          4. Patients with a medical condition other than atrial fibrillation for which chronic\n             use of an oral anticoagulant (for example, a VKA) is indicated."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients with non-valvular AF"
            }
        }, 
        "enrollment": {
            "#text": "2700", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01937377", 
            "org_study_id": "1160.171"
        }, 
        "lastchanged_date": "May 14, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Altdorf", 
                        "country": "Switzerland"
                    }, 
                    "name": "1160.171.44007 Boehringer Ingelheim Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland"
                    }, 
                    "name": "1160.171.44001 Boehringer Ingelheim Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland"
                    }, 
                    "name": "1160.171.44006 Boehringer Ingelheim Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland"
                    }, 
                    "name": "1160.171.44008 Boehringer Ingelheim Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lugano", 
                        "country": "Switzerland"
                    }, 
                    "name": "1160.171.44002 Boehringer Ingelheim Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Gallen", 
                        "country": "Switzerland"
                    }, 
                    "name": "1160.171.44004 Boehringer Ingelheim Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Urtenen-Schonbuhl", 
                        "country": "Switzerland"
                    }, 
                    "name": "1160.171.44005 Boehringer Ingelheim Investigational Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_groups": "1", 
        "official_title": "GLORIA-AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III-India and Switzerland)", 
        "overall_contact": {
            "email": "clintriage.rdg@boehringer-ingelheim.com", 
            "last_name": "Boehringer Ingelheim Call Center", 
            "phone": "1-800-243-0127"
        }, 
        "overall_official": {
            "affiliation": "Boehringer Ingelheim", 
            "last_name": "Boehringer Ingelheim", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "India: Drugs Controller General of India", 
                "Switzerland: Swissmedic"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "CHADS2 Score [cardiac failure, hypertension, age, diabetes, stroke (doubled)]", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "measure": "CHA2DS2-VASc Score [cardiac failure, hypertension, age >=75 (doubled), diabetes, stroke (doubled), vascular disease, age 65-74 and sex category (female)", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "measure": "HAS-BLED score [hypertension, abnormal renal/liver function (1 point each), stroke, bleeding history or predisposition, labile International Normalized Ratio (INR), elderly (>65), drugs/alcohol concomitantly (1 point each)]", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "measure": "Antithrombotic treatment choice at baseline", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "measure": "Stroke (hemorrhagic and ischemic, uncertain classification)", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }, 
            {
                "measure": "Transient Ischemic Attach (TIA)", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }, 
            {
                "measure": "Systemic embolism", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }, 
            {
                "measure": "Pulmonary embolism", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }, 
            {
                "measure": "Myocardial infarction", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }, 
            {
                "measure": "Life-threatening bleeding events", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }, 
            {
                "measure": "Major bleeding events", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }, 
            {
                "measure": "All cause death", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }, 
            {
                "measure": "Non-vascular death", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }, 
            {
                "measure": "Death of unknown cause", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }, 
            {
                "measure": "Vascular death", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }, 
            {
                "measure": "Composite endpoint: stroke, systemic embolism, myocardial infarction, life-threatening bleeding events and vascular death", 
                "safety_issue": "Yes", 
                "time_frame": "up to 3 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01937377"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Boehringer Ingelheim", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boehringer Ingelheim", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}